Methotrexate: The Once-a-Week Drug That Anchors Rheumatology
Methotrexate is the single most important drug in rheumatology — the first-line, 'anchor' DMARD for rheumatoid arthritis. It also carries one of medicine's most dangerous dosing traps: it's taken ONCE A WEEK, and confusing that for a daily dose has killed people. Understanding this one drug well is genuinely life-and-death knowledge.
If you learn only one DMARD, learn methotrexate. It's the first-line, foundation drug for rheumatoid arthritis — the one nearly every patient starts on, and the one other drugs are usually added to. It's called the 'anchor' DMARD for that reason. Methotrexate works by interfering with folate (a B vitamin the body needs to make DNA), which dampens the rapidly-dividing immune cells driving the inflammation. Interestingly, at much higher doses methotrexate is also a cancer chemotherapy drug — but in rheumatoid arthritis it's used at a much lower dose for its immune-calming effect. It's effective, well-established and relatively cheap, which is why it anchors treatment. But two features make it a drug you must understand precisely: an unusual dosing schedule that is genuinely dangerous if confused, and a clever antidote-like partner drug.
The once-a-week rule — a lethal trap
Methotrexate for arthritis is taken ONCE A WEEK, not daily. This is the single most important safety fact about methotrexate, and it has genuinely caused deaths: in rheumatoid arthritis, methotrexate is taken ONCE A WEEK, not every day. Almost every other tablet a person takes is daily, so both patients and, tragically, sometimes healthcare staff have mistakenly given methotrexate daily — and a week's dose taken every day quickly becomes a massive overdose, causing severe bone-marrow suppression (the blood cells collapse), mouth ulcers, and death. This is such a well-recognised danger that it's surrounded by safety systems: careful counselling, specific packaging, and prescribing checks all built around the once-weekly rule. When you see methotrexate, the first thing that should flash in your mind is 'once a week'. There's a related monitoring point: because methotrexate suppresses the bone marrow, liver and can affect the lungs, patients need regular blood tests to catch problems early. And because it interferes with folate, alcohol (also hard on the liver) is limited. The once-weekly rule isn't a quirk to memorise for an exam — it's a real-world safety imperative.
Folate, and its antidote
The second thing to understand about methotrexate flows from how it works, and it's genuinely elegant. Since methotrexate acts by interfering with folate, many of its side effects come from that folate blockade — mouth ulcers, nausea, and effects on the blood counts. So we give patients a folate supplement (folic acid) alongside methotrexate, on a different day of the week, to reduce these side effects without blocking the drug's therapeutic action. It's a simple, clever pairing that makes methotrexate much better tolerated. And there's an even more striking related fact for emergencies: if someone has methotrexate toxicity or overdose, there's a specific rescue drug called folinic acid (leucovorin) — a form of folate that bypasses the block methotrexate creates, rapidly restoring the body's folate supply and reversing the toxicity. So the folate story gives methotrexate both a routine side-effect-reducer (folic acid) and an emergency antidote (folinic acid). Understand that methotrexate is fundamentally a folate-blocker, and its therapeutic use, its side effects, its supportive folic acid, and its antidote all fall into place — a tidy example of how knowing one mechanism explains a whole cluster of clinical facts.
- Methotrexate is the first-line 'anchor' DMARD for rheumatoid arthritis — a folate-blocker that calms immune cells.
- CRITICAL: taken ONCE A WEEK, not daily — daily dosing is a lethal overdose (bone-marrow suppression).
- Give folic acid (a different day) to reduce side effects (mouth ulcers, nausea, low counts).
- The antidote for methotrexate toxicity is folinic acid (leucovorin) — bypasses the folate block.
- Monitor blood counts, liver and lungs; limit alcohol; suppresses immunity (infection risk).
Methotrexate is a rare example where a dosing schedule, not the drug's biology, is the most important thing to know — because getting it wrong is lethal. Almost every medicine is taken daily, so 'once a week' cuts against a deep habit, and the consequence of the mistake is catastrophic: a week's worth taken every day rapidly wipes out the bone marrow. This is why methotrexate is wrapped in more safety systems than almost any other tablet. It's a sobering reminder that a drug's danger isn't always in its pharmacology — sometimes it's in the simple human error of how it's taken. And the folate theme is the perfect counterpoint: understand that methotrexate blocks folate, and you understand its action, its side effects, the folic acid we give to soften them, and folinic acid, the antidote that refills folate directly. One mechanism, and a whole clinical picture reads straight off it — but never forget the once-a-week rule sitting on top.
- Taking/giving methotrexate DAILY instead of once weekly — a lethal overdose.
- Forgetting folic acid — it reduces side effects (take on a different day from methotrexate).
- Not monitoring blood counts, liver and lungs on methotrexate.
- Confusing folic acid (routine supplement) with folinic acid (the toxicity antidote).
What is the most critical dosing rule for methotrexate in rheumatoid arthritis?
- Methotrexate is the first-line anchor DMARD for RA — a folate-blocker that calms the immune attack.
- CRITICAL: it's taken ONCE A WEEK — daily dosing is a lethal overdose.
- Give folic acid (different day) to reduce side effects; folinic acid is the toxicity antidote.
- Monitor blood counts/liver/lungs; limit alcohol; suppresses immunity.
- Katzung BG. Basic & Clinical Pharmacology — DMARDs (methotrexate).
- Brunton LL, et al. Goodman & Gilman's The Pharmacological Basis of Therapeutics — Methotrexate & antifolates.
- ACR / EULAR — Methotrexate in rheumatoid arthritis; safety alerts on weekly dosing.
- Whalen K. Lippincott Illustrated Reviews: Pharmacology — Methotrexate.
